共 50 条
- [1] Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: results up to Week 48 of the STARDUST trial [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S330 - S331
- [4] The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 (08): : 883 - 895
- [5] Clinical and endoscopic response to ustekinumab in Crohn's disease: Week 16 interim analysis of the STARDUST trial [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S049 - S052
- [9] Efficacy of the treat-to-target approach in modifying disease course with ustekinumab in patients with moderate-to-severe Crohn's Disease: Results from the STARDUST trial [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I132 - I134